Lataa...
BRCA testing delay during the COVID-19 pandemic: How to act?
Recently, our lab, part of a referral center in Italy, reported its experience regarding the execution of germline BRCA1/2 (gBRCA) testing during the first months of the coronavirus disease-2019 (COVID-19) pandemic, which highlights a substantial reduction (about 60%) compared with the first 2 month...
Tallennettuna:
| Julkaisussa: | Mol Biol Rep |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Netherlands
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733534/ https://ncbi.nlm.nih.gov/pubmed/33313973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11033-020-06060-8 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|